On Wednesday, Callidus Software Inc. (NASDAQ:CALD)’s shares inclined 1.49% to $17.70.
TNT Express, one of the world’s largest express delivery companies, has selected CallidusCloud CPQ (Configure, Price, Quote) to accelerate the creation of customer quotes, according to Callidus Cloud (CALD), a global leader in cloud-based sales, marketing, learning and customer experience solutions. The contract was signed in the third quarter.
TNT Express, which delivers nearly 1 million items every day ranging from parcels and documents to palletized freight, will rely on CallidusCloud CPQ to slash the time it takes to get quotes into customers’ hands and enhance the number of quotes each sales representative can generate.
The move to CPQ is part of a strategy by TNT Express to transform and simplify its business processes, and CallidusCloud offered what the company was looking for off the shelf, reducing implementation costs.
Callidus Software Inc. provides enterprise software and related services to telecommunications, insurance, banking, and technology markets worldwide. It offers Marketing Automation to generate sales leads by capturing intelligence about buyers’ behaviors and engaging them across multiple channels; Territory and Quota to evaluate territory, quota distribution plans, and strategies for meeting corporate sales aims; Enablement that provides sales content at each step of the sales cycle; Litmos Learning Administration System for training; Litmos Content to create courses that can be published to desktop browsers and mobile devices; and Sales Performance Manager to set targeted coaching plans to the individual sales professional.
Dr.Reddy’s Laboratories Ltd (ADR) (NYSE:RDY)’s shares gained 1.81% to $61.71.
Dr. Reddy’s Laboratories (RDY) declared the signing of a commercialization deal with Hatchtech, an Australian pharmaceutical company developing an innovative prescription head lice product, Xeglyze™ Lotion. The exclusive rights for this product are applicable for the territories of the United States, Canada, India, Russia and the CIS, Australia, New Zealand and Venezuela.
Additionally, Hatchtech declared it will be filing its New Drug Application for Xeglyze™ with the US Food and Drug Administration (FDA) recently. If approved, the product will be marketed in the United States by Promius Pharma, a wholly-owned specialty company of Dr. Reddy’s Laboratories.
As part of the agreement, Dr. Reddy’s will pay Hatchtech an upfront amount of US $10MM, up to US $50 million based on pre commercialization milestones and an unrevealed amount based on post commercialization milestones, linked to achievement of annual net sales targets.
Dr. Reddy’s Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment produces and markets finished pharmaceutical products as branded formulations or generic finished dosages. This segment also engages in biologics business.
At the end of Wednesday’s trade, Saia Inc (NASDAQ:SAIA)‘s shares dipped -0.05% to $36.42.
Saia, Inc., (SAIA), a leading transportation provider offering less-than-truckload, non-asset truckload, and logistics services, recently declared the board of directors has elected Randolph W. Melville as a director of the corporation and named him a member of the compensation committee.
Melville was an independent director and member of the compensation committee of Interline Brands, Inc. proceeding to its merger with a private equity acquirer in September 2012.
Proceeding to his 20-plus years at Frito-Lay, Melville held numerous leadership positions at Procter & Gamble and Maytag Corporation. He received his undergraduate degree from Princeton University.
Saia, Inc., through its auxiliaries, operates as a transportation company in the United States. It provides regional and interregional less-than-truckload, truckload, guaranteed, expedited, and logistics services.
Heritage Insurance Holdings Inc (NYSE:HRTG), ended its Wednesday’s trading session with -2.15% loss, and closed at $19.11.
Heritage Insurance Holdings, Inc. (HRTG), a property and casualty insurance holding company, recently declared that the Company’s Board of Directors has authorized the repurchase of up to $20 million of its outstanding shares of common stock through December 31, 2016.
Under the program, purchases may be made from time to time in the open market, or through privately negotiated transactions, block transactions, or other techniques, as determined by the Company’s administration and in accordance with prevailing market conditions and the requirements of the Securities and Exchange Commission. Heritage anticipates to fund all purchases from cash on hand and future cash flows from operations. The Company is not obligated to acquire a particular number of shares, and the program may be suspended at any time at the Company’s discretion.
Heritage Insurance Holdings, Inc. operates as a property and casualty insurance holding company in the state of Florida. The company, through its partner, Heritage Property & Casualty Insurance Company, offers personal residential insurance for single-family homeowners and condominium owners; rental property insurance; and commercial residential insurance. As of December 31, 2014, it had about 207,000 personal residential policies and 2,400 commercial residential policies in force.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
